somatostatin analogue that suppresses GH/IGF-I hypersecretion in acromegaly patients and used to manage neuroendocrine tumours; do not confuse with BIM 23014 C
Also Known As:
Somatuline; 188Re-lanreotide; 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide; 3-(2-naphthyl)-D-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2; 3-(2-naphthyl)alanyl-cystinyl-tyrosyl-tryptophyl-lysyl-valyl-cystinyl-threonine amide; BIM 23014; BIM 23014 C; BIM 23014C; BIM-23014; BIM-23014 C; D-Nal-Cys-Tyr-Trp-Lys-Val-Cys-Thr-NH2; DC 13-116; DC-13-116; DC13-116; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide; Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)-Thr-NH2; Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2; Somatulin; Somatulina; angiopeptin; lanreotide acetate; lanreotide-SR; naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide; naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2; L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide